As deadly ‘superbugs’ outsmart antibiotics, a Penn scientist uses artificial intelligence to design new ones
04 November 2019
In his lab at the University of Pennsylvania, de la Fuente and his team use computer algorithms to design and refine new drugs, sifting through chemical building blocks for combinations that are predicted to penetrate bacterial defenses.
Further reading: The Philadelphia Inquirer
Author(s): Tom Avril
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
